MARIE FRANZ: Open Payments
NPI 1184297038 · SHELBY TOWNSHIP, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,471 in 72 payments from 20 companies in 2025. Trend: 2023 $2,528 · 2024 $1,686 · 2025 $1,471
Food & beverage: $1,451Education: $20
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $181 |
| SCPHARMACEUTICALS INC. | 9 | $175 |
| AstraZeneca Pharmaceuticals LP | 7 | $160 |
| Merck Sharp & Dohme LLC | 5 | $129 |
| Novartis Pharmaceuticals Corporation | 5 | $111 |
| Amgen Inc. | 6 | $96 |
| E.R. Squibb & Sons, L.L.C. | 5 | $88 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $78 |
| Alnylam Pharmaceuticals Inc. | 4 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $75 |
Products named: Wegovy, FUROSCIX, VERQUVO, REPATHA, LEQVIO, ELIQUIS, LifeVest, Kerendia.
Industry payments across MI — which companies pay providers there.
